Italy said on Wednesday it was seeking more than a billion euros in damages from multinational drug companies following a ruling by the country's antitrust authority that their policies had been detrimental to Italy's national health service. The health ministry said in a statement it was requesting a total 1.2 billion euros ($1.6 billion) from Novartis (NOVN.VX) and Roche (ROG.VX) for the damages incurred in 2012-2014, and was requesting 14 million euros from Pfizer (PFIZ.NS). It cited several recent antitrust rulings that the companies' repeated anti-competitive actions had caused the national health service "considerable damage".
Help employers find you! Check out all the jobs and post your resume.
